Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 13/1/2021
SIETES contiene 93213 citas

 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Fournier J-P, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc J-L. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol 2012;68:1533-40. [Ref.ID 93963]
2.Enlace a cita original Cita con resumen
Montastruc F, Sommet A, Bondon-Guitton E, Durrieu G, Bui E, Bagheri H, Lapeyre-Mestre M, Schmitt L, Montastruc J-L. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. Eur J Clin Pharmacol 2012;68:767-75. [Ref.ID 92823]
3.Tiene citas relacionadas Cita con resumen
Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strenghts of the disproportionality analysis of identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 2011;72:905-8. [Ref.ID 91873]
4. Cita con resumen
Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, Montastruc J-L, Bagheri H. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées Region (PharmacoMIP) Network 2-year pilot study. Drug Saf 2010;33:409-16. [Ref.ID 88434]
5.Enlace a cita original
Montastruc G, Favreliere S, Sommet A, Pathak A, Lapeyre-Mestre M, Perault-Pochat M-C, Montastruc J-L, The French Association of Regional PharmacoVigilance Centres. Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol 2010;69:marzo. [Ref.ID 87941]
6.Tiene citas relacionadas
Sommet A, Pathak A, Montastruc J-L. Tesofensine and weight loss. Lancet 2009;373:719. [Ref.ID 85373]
7. Cita con resumen
Gallini A, Sommet A, Montastruc J-L, and the French PharmacoVigilance Network. Does memantine induce bradycardia? A study in the French FarmacoVigilance Database. Pharmacoepidemiol Drug Saf 2008;17:877-81. [Ref.ID 83994]
8. Cita con resumen
Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc J-L, Bagheri H. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2007;63:221-8. [Ref.ID 79523]
Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc J-L, and the French Network of PharmacoVigilance centres. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf 2006;15:735-40. [Ref.ID 78584]
10. Cita con resumen
Sommet A, Juillard-Condat B, Cestac P, Lapeyre-Mestre M, Montastruc J-L. Méthodes de mesure de la consommation médicamenteuse: application aux antibiotiques. Therapie 2005;60:553-9. [Ref.ID 76311]
Seleccionar todas
 1 a 10 de 10